S

Sangamo Therapeutics

D

SGMO

USD

0.0617

(7.3584%)

Market Closed

89,563.00

حجم التداول

-0.435

الربح لكل سهم

-

العائد الربحي

-0.652319

P/E

187,440,247.13

حجم السوق

اليوم

7.3584%

1 اسبوع

10.958%

1 شهر

3.471%

6 اشهر

15.262%

12 اشهر

6.356%

بداية السنة

66.365%

كل الوقت

0%

أصول ذات صلة

Title:
Sangamo Therapeutics

Sector:

Healthcare

Industry:

Biotechnology

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا